Hilton La Jolla Torrey Pines to Host Premier Lateral Flow Event with Enhanced Programming
LA JOLLA, Calif., Feb. 27, 2025 /PRNewswire/ — The 2025 Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is set to take place Oct. 14-15, 2025, in a stunning new location: the Hilton La Jolla Torrey Pines in La Jolla, California.
Known for its picturesque coastal views and world-class amenities, La Jolla offers attendees an upgraded experience while maintaining the convenience of southern California. The Hilton La Jolla Torrey Pines, located at 10950 North Torrey Pines Road, provides spacious accommodations, state-of-the-art facilities, and a serene environment that fosters both networking and innovation.
“We’re excited to host this year’s ALFC in La Jolla,” said Mitzi Rettinger, chair of the ALFC 2025 organizing committee. “The Hilton La Jolla Torrey Pines not only exceeds our needs for space and comfort but also offers attendees an incredible setting to connect and exchange ideas.”
Attendees will enjoy the same exceptional programming they’ve come to expect, including opportunities to engage with industry leaders, explore the latest technologies, and gain valuable insights into trends and commercialization strategies. The 2025 conference also promises exciting new features designed to enhance the experience and provide even greater value.
DCN Dx is offering special negotiated hotel rates for ALFC attendees. For more information and to book your stay, visit https://book.passkey.com/e/50944789. Prefer to call in your reservation? Call the Hilton La Jolla Torrey Pines at (877) 414-8020 and use Group Reservation Code ADVLAT.
To learn more and to register, visit ALFC2025.com.
About the Advanced Lateral Flow Conference
The Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is the leading global event for lateral flow diagnostic developers, manufacturers, and those driving their commercial success. This annual conference delivers cutting-edge insights through expert-led sessions and provides a platform for researchers and developers to exchange ideas and innovations. Attendees gain practical insights to advance their businesses, deepen their knowledge of rapid diagnostics, and connect with leading minds shaping the future of point-of-care testing. To learn more about ALFC, visit alfc2025.com.
About DCN Dx
DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research. DCN Dx’s multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory services.
DCN Dx’s personalized approach to IVD product development and clinical trials has supported hundreds of programs and clients. They can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, DCN Dx’s clinical research expertise extends to any in vitro diagnostic, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.
MEDIA CONTACT
Mitzi Rettinger
Chief Revenue Officer, DCN Dx
Main: (760) 804-3886
Mobile: (512) 431-5836
390793@email4pr.com
SOURCE DCN Dx
